GelMA ‐based 3D spheroids recapitulate transcriptomic and functional hallmarks of myeloid sarcoma
FEBS Open Bio · 13.08.2026
DOI: 10.1002/2211-5463.70321 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, online erschienen am 13.08.2026. Verfasst von Nicolas Germain und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Lille, CNRS, Inserm, CHU Lille, Institut de Recherche Contre le Cancer de Lille, UMR9020 - UMR-S 1277 - Canther Cancer Heterogeneity, P…. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ligue contre le cancer - comité du Nord and Cancéropole Nord Ouest, Cancéropole Nord Ouest, Appel à projet Emergence.
Abstract (Originalsprache)
Myeloid sarcoma (MS) is a rare extramedullary manifestation of acute myeloid leukemia (AML). Conventional two‐dimensional cultures fail to replicate the constraints of the MS microenvironment. We demonstrated that 5% gelatin methacrylate (GelMA) hydrogels provide a tunable three‐dimensional matrix for in vitro modeling of MS. GelMA hydrogels exhibited tissue‐like stiffness and oxygen diffusion properties, supporting the formation of viable spheroids from myeloid leukemia cell lines. The 3D context induced G1 cell cycle arrest and apoptotic progression, reflecting dormancy at extramedullary sites. RNA sequencing revealed transcriptional reprogramming in GelMA‐embedded spheroids, with an enrichment in ECM remodeling and metabolic pathways. Furthermore, transcriptomic profiles from 3D‐cultured cells aligned with patient‐derived MS samples, validating the model's relevance to MS. Thus, we present a GelMA‐based system which provides a clinically relevant platform for investigating MS biology and screening potential therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Lille, CNRS, Inserm, CHU Lille, Institut de Recherche Contre le Cancer de Lille, UMR9020 - UMR-S 1277 - Canther Cancer Heterogeneity, Plasticity and Therapy Resistance, France.
- Banque de Tissus, Centre de Biologie-Pathologie, CHU Lille, France.
- Institut de Pahtologie, Centre de Biologie-Pathologie, CHU Lille, France.
- University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, France.
- Service de Biochimie, Centre de Biologie-Pathologie, CHU Lille, France.
- University of Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE-Facteurs de Risque et Déterminants Moléculaires des Maladies Liées au Vieillissement, France.
ORCID-Profile: Nicolas Germain, Nicolas Touya
Förderung
- Ligue contre le cancer - comité du Nord and Cancéropole Nord Ouest
- Cancéropole Nord Ouest, Appel à projet Emergence
Zitieren
APA
Germain, N., Buret, E., Nguyen, L. H. T., Cocheteux, M., Touya, N., Dhayer, M., Dubois, R., Lafont, F., Janel, S., Maboudou, P., Lancel, S., & Marchetti, P. (2026). GelMA ‐based 3D spheroids recapitulate transcriptomic and functional hallmarks of myeloid sarcoma. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70321
Vancouver
Germain N, Buret E, Nguyen LHT, Cocheteux M, Touya N, Dhayer M, et al. GelMA ‐based 3D spheroids recapitulate transcriptomic and functional hallmarks of myeloid sarcoma. FEBS Open Bio. 2026. doi:10.1002/2211-5463.70321
BibTeX
@article{Germain2026,
author = {Germain, Nicolas and Buret, Elise and Nguyen, Le Hoang Thanh and Cocheteux, Marion and Touya, Nicolas and Dhayer, Mélanie and Dubois, Romain and Lafont, Frank and Janel, Sebastien and Maboudou, Patrice and Lancel, Steve and Marchetti, Philippe},
title = {GelMA ‐based 3D spheroids recapitulate transcriptomic and functional hallmarks of myeloid sarcoma},
journal = {FEBS Open Bio},
year = {2026},
doi = {10.1002/2211-5463.70321}
}
EUVIMED